7 weeks opn the No. 1 spot of the African Top Ten charts, Peggy’s Masechaba has struck a powerful note with the people of South Africa and Africa. Composed b…
Video Rating: 5 / 5
There are more than 42 million HIV-infected people in the world; nearly 30 million of those are in Africa (mostly sub-Saharan Africa). South Africa has the h…
Treating HIV-positive people with antiretroviral drugs at an earlier stage has many benefits. In this 5-part video-clip series, Médecins Sans Frontières demo…
Video Rating: 0 / 5
World AIDS Day 2012 DNDi entered into the field of paediatric HIV to find adapted treatments to address the urgent needs of babies and children living with H…
Video Rating: 0 / 5
Tuberculosis (TB) is the leading cause of death for people living with HIV in South Africa. The good news is that TB is completely curable if you take your medicine properly the first time around. If, however, you are not adherent to your medication, you run the risk of dying from TB. This programme deals with the effects of TB on HIV positive individuals and explains how TB can also occur outside of the lungs. It also looks at how to treat TB and the possible side-effects that may result, as well as Multi Drug-Resistant TB.
www.einstein.yu.edu – Immunology Lecture 13 of 14 “Failures in Host Defense Mechanisms.” Harris Goldstein, MD, director, Einstein-Montefiore Center for AIDS Research, professor of pediatrics and microbiology & immunology and the Charles Michael Chair in Autoimmune Diseases, delivers a mini-course that provides a comprehensive overview in basic immunology for graduate and medical students and for anyone interested in understanding how the immune system works. This mini-course was organized by the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) at the Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa to provide Sub-Saharan students, research trainees and HIV and TB investigators with a comprehensive course in immunology. (January 2010). See related lecture slides at: streaming.einstein.yu.edu
Video Rating: 5 / 5
Researchers in South Africa have found that a vaginal gel containing a prescription drug could dramatically cut the prevalence of HIV in woman. Results of a study in the country showed that the microbicide gel reduced the HIV infection rate by 39 per cent over two and a half years. Renowned singer Annie Lennox, who is also an AIDS activist, has told Al jazeera that the results of the gel trial is good news, but much more work still has to be done. [July 21, 2010]
Video Rating: 4 / 5